Partnerships Archives - AIT BioscienceAIT Bioscience


Category Archives for Partnerships

Is your all-in-one CRO providing you the expertise you need for your ocular studies?

  How a partnership of niche experts might better meet your needs by David Culp     When you are working with a simple small molecule drug candidate in a common species and plasma or serum matrix you don’t always need experts at the helm of your toxicology or bioanalytical studies. But when you are … read the full article » »

Other Categories: News

Tags: , ,

Comments Off on Is your all-in-one CRO providing you the expertise you need for your ocular studies?


Partnering for Results

Partnering for Results AIT Bioscience Highlights Partnerships   At AIT Bioscience, partnering is just part of the way we operate. We want to be your partner in the drug development process, and now we would like to introduce you to some of our partners.   On our new Partnership page, you can find links to … read the full article » »

Tags: , , , , , , , , , , ,

Comments Off on Partnering for Results


Antibody Drug Conjugate Analysis: How Partnering with a Bioanalytical CRO Can Ease Preclinical ADC Programs

The potential of antibody drug conjugates (ADCs) to provide targeted therapies for cancers and other devastating diseases have made them popular candidates for drug development programs. However, as we discussed recently in Drug Discovery and Development, the failure of several ADCs during phase II and III trials due to limited efficacy proves more complete bioanalysis … read the full article » »

Other Categories: Biomarkers, LC-MS/MS Methods, Ligand Binding Assays (LBA)



Comments Off on Antibody Drug Conjugate Analysis: How Partnering with a Bioanalytical CRO Can Ease Preclinical ADC Programs


What Level of Bioanalytical Method Validation is Right for My Early Stage Drug Development Study?

During late phase drug discovery, everyone follows well established FDA bioanalytical method validation guidelines. However, opinions vary widely about what validation is necessary for early- to mid-phase studies. We are often asked by our clients: “How robust do I need this assay to be?” “At what point can I use this data to present to … read the full article » »

Other Categories: LC-MS/MS Methods, Ligand Binding Assays (LBA)



Comments Off on What Level of Bioanalytical Method Validation is Right for My Early Stage Drug Development Study?